-
About Pfizer
Pfizer Incorporated (PFE) is a major pharmaceutical company, which ranks number one in sales. The company is based in New York City. It produces the number-one selling drug Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the long-acting antibiotic Zithromax (azithromycin), the well-known erectile dysfunction drug Viagra (sildenafil citrate), and the anti inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside USA and Canada, mainly in South America).
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.
With 2005 actual spending of $7.4 billion in research & development (R&D;), Pfizer boasts the industry's largest pharmaceutical R&D; organization: Pfizer Global Research and Development. -
Related Topics
Mashable's Weekly Guide to Social Media and Internet Events | Vc ...
11 articles also mentioned EnterprisePaula Abdul Leads the Way among Celebrity Twitterers: Outdoes ...
11 articles also mentioned Thought LeaderMashable's Weekly Guide to Social Media and Internet Events | Vc ...
10 articles also mentioned Social MediaInmagic Hosts Industry Thought Leadership Podcast Series
8 articles also mentioned MRAInmagic Hosts Industry Thought Leadership Podcast Series
8 articles also mentioned Laureate EducationInmagic Hosts Industry Thought Leadership Podcast Series
8 articles also mentioned EdmontonInmagic Hosts Industry Thought Leadership Podcast Series
8 articles also mentioned Social Knowledge Network









Recent Comments
MonicaPRATT23 » Beyond Random Content: Four Steps to Thought Leadership Success: A June 3, 2010 Webinar
Do you know that it is high time to receive the <a href="http://lowest-rate-loans.com">loans</a>, which will ...
Taariq Lewis » Beyond Random Content: Four Steps to Thought Leadership Success: A June 3, 2010 Webinar
Webinar from a visionary marketer and thought leadership expert.
See all recent comments